✦ LIBER ✦

Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study

✍ Scribed by Kemal Sagduyu; Mehmet E Dokucu; Bruce A Eddy; Gerald Craigen; Claudia F Baldassano; Ayşegül Yıldız

Book ID: 119900923
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 505 KB
Volume: 4
Category: Article
ISSN: 1475-2891
DOI: 10.1186/1475-2891-4-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Behavioral Effects of Omega-3 Fatty Acid

Behavioral Effects of Omega-3 Fatty Acid Supplementation in Young Adults with Severe Autism: An Open Label Study

✍ Pierluigi Politi; Hellas Cena; Mario Comelli; Gaetano Marrone; Chiara Allegri; E 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Mon-P68 - Clinical experience with gabap

Mon-P68 - Clinical experience with gabapentin in patients with bipolar disorder: Results of an open label study

✍ P.L. Cabras; J. Hardoy; C. Hardoy 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 242 KB

An open-label, add-on study of pregabali

An open-label, add-on study of pregabalin in patients with partial seizures: A multicenter trial in Greece

✍ Stefanos Tsounis; Vasilios K. Kimiskidis; Dimitrios Kazis; Konstantinos Gkiatas; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Phosphatidylserine Containing Omega-3 Fa

Phosphatidylserine Containing Omega-3 Fatty Acids May Improve Memory Abilities in Nondemented Elderly Individuals with Memory Complaints: Results from an Open-Label Extension Study

✍ Vakhapova, Veronika; Cohen, Tzafra; Richter, Yael; Herzog, Yael; Kam, Yossi; Kor 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 532 KB

The effect of phosphatidylserine contain

The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: A double-blind placebo-controlled trial, followed by an open-label extension

✍ I. Manor; A. Magen; D. Keidar; S. Rosen; H. Tasker; T. Cohen; Y. Richter; D. Zaa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 362 KB

The Efficacy and Safety of Switching to

The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study

✍ Lee, Hwang-Bin; Yoon, Bo-Hyun; Kwon, Young-Joon; Woo, Young Sup; Lee, Jung-Goo; 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 381 KB